|
Alisertib Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: MLN8237, PB-8237
Pipeline
Phase 1: 1Phase 2: 2
Top Sponsors
- Puma Biotechnology, Inc.2
- Collin Blakely1
Indications
- Cancer3
- Lung Cancer2
- Recurrent Breast Cancer1
- Lung Cancer Metastatic1
- Metastatic Breast Cancer1
Birmingham, Alabama1 trial
Daphne, Alabama1 trial
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Southern Cancer Center
Phase 2
San Francisco, California1 trial
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
University of California, San Francisco
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.